Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
12/22/1994 | WO1994029332A1 Coiled-coil stem loop templates |
12/22/1994 | WO1994028942A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION |
12/22/1994 | WO1994028921A1 Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides |
12/22/1994 | WO1994028920A1 Synthetic peptide inhibitors of hiv transmission |
12/22/1994 | WO1994025606A3 Recombinant alanine racemase and gapdh from tolypocladium |
12/22/1994 | WO1994025477A3 Novel peptide nucleic acids |
12/22/1994 | CA2164880A1 Anti-inflammatory composition and method with des-tyr dynorphin and analogues |
12/22/1994 | CA2163996A1 Thrombin receptor radioligands and assays for identifying thrombin receptor antagonists |
12/22/1994 | CA2163905A1 Inhibiting protein interactions |
12/21/1994 | EP0629636A1 Lipopeptides from actinoplanes sp. endowed with pharmacological activity, process for their preparation and their use |
12/21/1994 | EP0629393A2 A crystalline polyol composition |
12/21/1994 | EP0629210A1 Peptide linkage unit comprising methylene phosphinic acid |
12/21/1994 | EP0629133A1 Protein- and peptide-metal ion pharmaceutical applications |
12/21/1994 | EP0624059A4 Combinatorial strategies for polymer synthesis. |
12/21/1994 | EP0579763A4 Novel peptide compositions and uses therefor. |
12/21/1994 | EP0220273B1 Synthetic antigens for the detection of aids-related disease |
12/21/1994 | CN1096515A New peptides |
12/20/1994 | US5374622 Fibrinogen receptor antagonists |
12/20/1994 | US5374621 Neurotensin method for inhibiting vascular leakage |
12/20/1994 | US5374618 Calcitonin peptides, and gene related pharmaceutical compositions |
12/20/1994 | US5374431 Polypeptide chains having helical structure in aqueous environments containing crosslinkable surface adherable amino acids; form insoluble matrix for adhering cells |
12/20/1994 | CA1333647C Heptapeptide analogs of somatostatin |
12/20/1994 | CA1333646C Biologically active lysine containing octapeptides |
12/14/1994 | EP0628571A1 Novel peptide, and antithrombotic agent, anticoagulant for extracorporeal circulation, cell fusion inhibitor, cancer metastasis inhibitor, protective for platelet preparation for transfusion and pack of platelet preparation for transfusion |
12/14/1994 | EP0628079A1 Hepatitis c virus peptides |
12/14/1994 | EP0628053A1 Hepatitis e virus peptide antigens and antibodies |
12/14/1994 | EP0471030B1 Glycoprotein hormone receptor molecules |
12/14/1994 | CN1096223A Vaccines raising immunological response against viruses causing porcing respiratory and reproductive diseases |
12/14/1994 | CN1096221A Substained-release preparation |
12/13/1994 | US5373089 Oxytocin antagonist |
12/13/1994 | US5372933 Antibody-polypeptide immunocomplex |
12/13/1994 | US5372809 Antigenic matrix metalloproteinase peptides |
12/08/1994 | WO1994028173A1 Association peptides |
12/08/1994 | WO1994028116A1 Nucleic acid encoding amp-activated protein kinase |
12/08/1994 | WO1994028015A1 Lhrh antagonists |
12/08/1994 | WO1994028014A2 Peptide inhibitors of urokinase receptor activity |
12/08/1994 | WO1994028013A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
12/08/1994 | WO1994027641A1 Amplification of the vitamin b12 uptake system using polymers |
12/08/1994 | CA2163741A1 Peptide inhibitors of urokinase receptor activity |
12/08/1994 | CA2163226A1 Amplification of the vitamin b12 uptake system using polymers |
12/08/1994 | CA2163225A1 Lhrh antagonists |
12/08/1994 | CA2162610A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
12/07/1994 | EP0627006A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin. |
12/07/1994 | EP0626973A1 Phenylalanine analogs of bombesin |
12/07/1994 | EP0416035B1 Amphiphilic peptides and use thereof |
12/06/1994 | US5371186 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
12/06/1994 | US5371071 Peptide and pseudopeptide compounds which are therapeutically active in the blood coagulation cascade |
12/06/1994 | US5371070 Bicyclic GnRH antagonists and a method for regulating the secretion of gonadotropins |
12/06/1994 | US5370991 Cloned gene encoding human monocyte elastase inhibitor |
12/06/1994 | CA1333441C Solid phase peptide synthesis |
12/05/1994 | CA2125080A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors |
11/30/1994 | EP0626452A1 Vaccine against Streptococcus suis infection |
11/30/1994 | EP0625988A1 Allosteric modulators of the nmda receptor |
11/30/1994 | EP0191813B1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
11/30/1994 | CN1095724A Novel peptides the preparation and use thereof |
11/29/1994 | US5369094 Polypeptide bombesin antagonists |
11/29/1994 | US5369093 Lipopeptide derivatives |
11/24/1994 | WO1994026906A2 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE |
11/24/1994 | WO1994026886A2 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
11/24/1994 | WO1994026780A1 Synthetic aglucodalbaheptide antibiotics |
11/24/1994 | WO1994026779A1 PROCESSES AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS |
11/24/1994 | WO1994026777A1 Thrombin inhibitors |
11/24/1994 | WO1994026776A1 Therapeutic compounds |
11/24/1994 | WO1994026773A1 Regulation of antigen presentation |
11/24/1994 | WO1994026306A1 Conserved motif of hepatitis c virus e2/ns1 region |
11/24/1994 | WO1994026296A1 Novel opioid peptide inhibitors |
11/24/1994 | WO1994026295A1 Metal chelates as spacer compounds in biologically active peptides |
11/24/1994 | WO1994026292A1 Amylin antagonists and agonists |
11/24/1994 | WO1994015961A3 Synthetic amphipathic peptides with antimicrobial activity |
11/24/1994 | CA2163020A1 Novel opioid peptide inhibitors |
11/24/1994 | CA2162113A1 Processes and intermediate compounds useful for the preparation of platelet glycoprotein iib/iiia inhibitors |
11/24/1994 | CA2159728A1 Synthetic aglucodalbaheptide antibiotics |
11/24/1994 | CA2139651A1 Amylin antagonists and agonists |
11/23/1994 | EP0625203A1 Synthetic haemophilus influenzae conjugate vaccine |
11/23/1994 | EP0625164A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
11/23/1994 | EP0575522A4 Polypeptides derived from the human immunodeficiency virus endonuclease protein. |
11/23/1994 | EP0535088A4 Chimeric toxins with improved inter-domain geometry |
11/23/1994 | EP0531461B1 Biologically active peptides containing d-2-alkyltryptophan |
11/22/1994 | US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs) |
11/22/1994 | US5367053 Opioid peptide inhibitors |
11/22/1994 | US5366880 Antibiotic agent |
11/22/1994 | EP0642666A4 Hepatitis c assay. |
11/22/1994 | CA1333208C Peptide boronic acid inhibitors of trypsin-like proteases |
11/22/1994 | CA1333150C Method for the control of pneumocystis carinii |
11/18/1994 | CA2123921A1 Polypeptide compound and a process for preparation thereof |
11/17/1994 | EP0624164A1 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
11/17/1994 | EP0624163A1 Cyclic calcitonin derivatives and method for their production |
11/17/1994 | EP0624059A1 Combinatorial strategies for polymer synthesis |
11/17/1994 | EP0540676B1 Peptide compounds having growth hormone releasing activity |
11/16/1994 | CN1095072A Difluoro pentapeptide derivative anti-inflammatory agents |
11/15/1994 | US5364851 Internal coupling/cyclization to form helical structures |
11/15/1994 | US5364840 Synthetic calcitonin peptides |
11/15/1994 | US5364838 Method of administration of insulin |
11/10/1994 | WO1994025606A2 Recombinant alanine racemase and gapdh from tolypocladium |
11/10/1994 | WO1994025602A1 Hepatitis-c virus type 4, 5 and 6 |
11/10/1994 | WO1994025573A1 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
11/10/1994 | WO1994025485A1 Oxytocin antagonist |
11/10/1994 | WO1994025477A2 Novel peptide nucleic acids |
11/10/1994 | WO1994025060A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
11/10/1994 | WO1994025050A1 Cyclohexapeptidyl propanolamine compounds |